François Laliberté

机构：Group for Research in Decision Analysis, Analysis Group (United States) · ORCID：0000-0003-2601-6214

发表论文 395 篇 · 总被引 3932 次 · h-index 31

代表论文

• Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study (2025 · Neurology and Therapy · 被引 12)
• Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy (2025 · Advances in Therapy · 被引 10)
• Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS) (2025 · Orphanet Journal of Rare Diseases · 被引 9)
• Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting (2025 · Annals of General Psychiatry · 被引 5)
• Real-World Persistence to Biologic Therapies and Its Impact on Outcomes in Patients With Asthma (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 3)
• Healthcare resource utilization and costs of using cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder (2025 · Journal of Medical Economics · 被引 3)